Recent developments in myelofibrosis

Autor: Mesa RA, Bogenberger JM, Tibes R

Publikováno v: Blood and Lymphatic Cancer: Targets and Therapy, Vol 2012, Iss default, Pp 125-136 (2012)

Raoul Tibes, James M Bogenberger, Ruben A MesaDivision of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USAAbstract: The myeloproliferative neoplasm of myelofibrosis (MF) is clinically constituted by individuals both with primary MF, as well

Externí odkaz: https://doaj.org/article/080eaffa2590496f87c9e93a7f5c44ed

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers.

Autor: Nagalo BM; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Department of Pathology , University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA.; The Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA., Zhou Y; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Loeuillard EJ; Division of Gastroenterology and Hepatology , Mayo Clinic , Rochester , Minnesota , USA., Dumbauld C; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Barro O; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Elliott NM; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Baker AT; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Arora M; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Bogenberger JM; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Meurice N; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Petit J; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Uson PLS Jr; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA.; Center for Personalized Medicine , Hospital Israelita Albert Einstein , São Paulo , Brazil., Aslam F; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Raupach E; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Gabere M; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Basnakian A; Department of Pathology , University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA.; Department of Pharmacology and Toxicology , University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA., Simoes CC; Department of Pathology , University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA.; The Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA., Cannon MJ; The Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA.; Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA., Post SR; Department of Pathology , University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA.; The Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences , Little Rock , Arkansas , USA., Buetow K; Computational Sciences and Informatics Program for Complex Adaptive System Arizona State University , Tempe , Arizona , USA., Chamcheu JC; School of Basic Pharmaceutical and Toxicological Sciences , College of Pharmacy, University of Louisiana , Monroe , Louisiana , USA., Barrett MT; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA., Duda DG; Steele Laboratories for Tumor Biology, Department of Radiation Oncology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA., Jacobs B; Center for Infectious Diseases and Vaccinology , the Biodesign Institute, Arizona State University , Tempe , Arizona , USA., Vile R; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Mayo Clinic Comprehensive Cancer Center , Phoenix , Minnesota , USA., Barry MA; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Mayo Clinic Comprehensive Cancer Center , Phoenix , Minnesota , USA.; Division of Infectious Diseases, Department of Internal Medicine , Mayo Clinic Rochester , Rochester , Minnesota , USA., Roberts LR; Division of Gastroenterology and Hepatology , Mayo Clinic , Rochester , Minnesota , USA., Ilyas S; Division of Gastroenterology and Hepatology , Mayo Clinic , Rochester , Minnesota , USA., Borad MJ; Department of Molecular Medicine , Mayo Clinic , Rochester , Minnesota , USA.; Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , Arizona , USA.; Mayo Clinic Comprehensive Cancer Center , Phoenix , Minnesota , USA.; Mayo Clinic Center for Individualized Medicine , Rochester , Minnesota , USA.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2023 Jun 01; Vol. 77 (6), pp. 1943-1957. Date of Electronic Publication: 2022 Oct 11.

Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers.

Autor: Arora M; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA., Bogenberger JM; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Abdelrahman AM; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Yonkus J; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Alva-Ruiz R; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Leiting JL; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Chen X; Department of Informatics, Mayo Clinic, Scottsdale, Arizona, USA., Serrano Uson Junior PL; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Dumbauld CR; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Baker AT; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Gamb SI; Microscopy and Cell Analysis Core, Mayo Clinic, Rochester, Minnesota, USA., Egan JB; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA., Zhou Y; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Nagalo BM; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Meurice N; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA., Eskelinen EL; Institute of Biomedicine, University of Turku, Turku, Finland., Salomao MA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona, USA., Kosiorek HE; Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, USA., Braggio E; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Barrett MT; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA., Buetow KH; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Sonbol MB; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Roberts LR; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Bekaii-Saab TS; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA., Ahn DH; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA., Truty MJ; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Borad MJ; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2022 Jan; Vol. 75 (1), pp. 43-58. Date of Electronic Publication: 2021 Dec 12.

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers.

Autor: Nagalo BM; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA., Breton CA; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Zhou Y; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Arora M; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Bogenberger JM; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Barro O; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Steele MB; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Jenks NJ; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Baker AT; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Duda DG; Department of Radiation Oncology, Steele Laboratories for Tumor Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA., Russell SJ; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA., Peng KW; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA., Borad MJ; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Molecular therapy oncolytics [Mol Ther Oncolytics] 2020 Sep 25; Vol. 18, pp. 546-555. Date of Electronic Publication: 2020 Aug 19.